InterCure Stock (NASDAQ:INCR)
Previous Close
$1.74
52W Range
$1.01 - $3.72
50D Avg
$1.89
200D Avg
$2.18
Market Cap
$79.40M
Avg Vol (3M)
$25.89K
Beta
0.06
Div Yield
-
INCR Company Profile
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.